Abstract
Vascular endothelial and -smooth muscle cells have been shown to use fatty acids as substrates for oxidative phosphorylation. Endothelial cells are more vulnerable to oxidative stress than muscle cells and are prone to loose carnitine early during hypoperfusion. This has been suggested by two observations. The first is that incubation of isolated endothelial cells in a low carnitine medium leads to oleate oxidation, dependent upon carnitine addition, whereas smooth muscle cells do not depend on carnitine addition duringin vitro incubation, although aminocarnitine, a specific inner-membrane carnitine palmitoyltransferase inhibitor, inhibits fatty acid oxidation. The second observation is that rat hearts labeledin vivo with14C-carnitine loose, as paced Langendorff heart, only 4% of their carnitine in 20 min perfusion, following 60 min global ischemia. The carnitine released had a much higher specific radioactivity than the carnitine that was not released. It indicates compartmentation of carnitine in heart. As earlier and presently discussed work shows endothelial vulnerability, it is to be expected that this cell type may become carnitine deficient during pacing and ischemia. Endothelial incompetence in flow regulation could be delaved by the presence of carnitine and fatty acids in pre-ischemia. It is speculated how activated fatty acids could protect endothelium.
Similar content being viewed by others
References
Dubelaar M-L, Lucas CMHB, Hülsmann WC: Acute effect of 1-carnitine upon skeletal muscle force tests in the dog. Am J Physiol 260: E189-E193, 1991
Dubelaar M-L, Lucas CMHB, Hülsmann WC: The effect of 1-carnitine on force development of m. latissimus dorsi in dogs. J Cardiac Surgery 6, suppl 1: 270–275, 1991
Hülsmann WC, Dubelaar M-L: Early damage of vascular endothelium during cardiac ischemia. Cardiovasc Res 21: 674–677, 1987
Hülsmann WC: Coronary vasodilation by fatty acids. Basic Res Cardiol 71: 179–191, 1976
Hülsmann WC, De Wit LEA, Schneydenberg C, Verkleij AJ: Loss of cardiac contractility and severe morphologic changes by acutely lowering the pH of the perfusion medium, protection by fatty acids. Biochim Biophys Acta 1033: 214–218, 1990
Hülsmann WC, Dubelaar M-L: Aspects of fatty acid metabolism in vascular endothelial cells. Biochimie 70: 681–686, 1988
Cederblad G, Lindstedt CD: A method for the determination of carnitine in the picomolar range. Clin Chim Acta 37: 235–243, 1972
Pearson DJ, Chase JFA, Tubbs PK: The assay of carnitine and its O-acylderivatives. In: SP Colowick and NO Kaplan (eds) Methods of Enzymol 14: 612–622, Academic Press Inc, 1969
Scholte HR, Luyt-Houwen IEM, Dubelaar M-L, Hülsmann WC: The source of malonyl-CoA in rat heart. The calcium paradox releases acetyl-CoA carboxylase and not propionyl-CoA carboxylase. FEBS Lett 198: 47–50, 1986
Hülsmann WC, Schneydenberg C, Verkleij AJ: Accumulation and excretion of long-chain acylcarnitines by rat heart, studies with aminocarnitine. Biochim Biophys Acta, in press, 1991
Wit-Peeters EM, Scholte HR, Van De Akker F, DeNie I: Intramitochondrial localization of palmitoyl-CoA-dehydrogenase, (ß-hydroxy-acyl-CoA-dehydrogenase and enoyl-CoA-hydrase in Guinea pig heart. Biochim Biophys Acta 231: 23–31, 1971
Idell-Wenger JA, Grotyohann LW, Neely JR: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310–4318, 1978
Ferrannini E, Buzzigoli G, Bevilaqua S, Boni C, DelChiaro D, Oleggini M, Brandi L, Maccari F: Interaction of carnitine with insulin-stimulated glucose metabolism in man. Am J Physiol 255: E964-E952, 1988
Siliprandi N, Di Lisa F, Pieralsi G, Ripari P, Maccari F, Menabo R, Giamberardino MA, Vecchiet L: Metabolic changes induced by maximal exercise in human subjects following L-carnitine administration. Biochim Biophys Acta 1034: 17–21, 1990
Spagnoli LG, Corsi M, Villaschi S, Palmieri G, Maccari F: Myocardial carnitine deficiency in acute myocardial infarction. Lancet i: 1419–1420, 1982
Hiatt WR, Regensteiner JG, Wolfel EE, Ruff L, Brass EP: Carnitine and acylcarnitine metabolism during exercise in humans. -dependence on skeletal muscle metabolic state. J Clir Invest 84: 1167–1173, 1989
Ferrari R, Cucchini F, Visioli O: The metabolic effects of L-carnitine in angina pectoris. Int J Cardiol 5: 213–216, 1984
Dobrina A, Rossi F: Metabolic properties of freshly isolated bovine endothelial cells. Biochim Biophys Acta 762: 295–301, 1983
Mertens S, Noll T, Spahr R, Krützfeldt A, Piper HM: Energetic response of coronary endothelial cells to hypoxic. Am J Physiol 258: H689-H694, 1990
Odessey YY, Chase KV: Utilization of endogenous lipid, glycogen, and protein by rabbit aorta. Am J Physiol 243: H128-H132, 1982
Sacks T, Moldow CF, Craddock PR, Bowers TK: Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. Anin vitro model of immune vascular damage. J Clin Invest 61: 1161–1167, 1978
Dauber JM, Van Benthuysen KM, McMurthy JF, Wheeler GS, Lesnefsky EJ, Horwitz LD, Neil JV: Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Cite Res 66: 986–998, 1990
Tsao PS, Lefer AM: Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol 259: H1660-H1666, 1990
Chance B, Sies H, Boveris H: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527–605, 1979
Mügge A, Elwell JH, Peterson TE, Harrison DG: Release of intact endothelium derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol 260: C219-C225, 1991
Lefer AM, Tsao PS, Lefer DJ, Ma XL: Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5: 2029–2034, 1991
Hülsmann WC, Dubelaar M-L, Lamers JMJ, Macari F: Protection by acyl-carnitines and phenylmethylsulfonylfluoride of rat heart subjected to ischemia and reperfusion. Biochim Biophys Acta 847: 62–66, 1985
Hülsmann WC, Dubelaar M-L: Carnitine in metabolism of paced cardiac and skeletal muscles; prevention of acidosis and improvement of vascular flow. In: L. Carnitine and its role in medicine, from function to therapy. R. Ferrari, S. Di Mauro, G. Sherwood, eds. Academic Press Ltd (1992) pp. 345–358.
Paulson DJ, Traxler J, Schmidt M, Nooman J, Shug AL: Protection of the ischemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischemia and reperfusion, carnitine transport and fatty acid oxidation. Cardiovasc Res 20: 536–541, 1986
Liedtke AJ, DeMaison L, Nellis SH: Effect of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 255: H169-H176, 1988
Sassen LMA, Bezstarosti K, Koning MMG, Van Der Giessen WJ, Lamers JMJ: Effects of administration of L-propionylcarnitine during ischemia on the recovery of myocardial function in the anaesthetized pig. Cardioscience 1: 155–161, 1990
Di Lisa F, Menabo R, Siliprandi N: L-propionylcarnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem 88: 169–173, 1989
Maxwell L, Gavin JB: The contribution of ischaemia to the development of microvascular incompetence in the myocardium. Cardiovasc Res 25: 491–495, 1991
Van Hinsberg VWM, Scheffer MA: Effect of L-propionylcarnitine on human endothelial cells. Cardiovasc Res Ther 5: 97–106, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hülsmann, W.C., Dubelaar, M.L. Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia. Mol Cell Biochem 116, 125–129 (1992). https://doi.org/10.1007/BF01270579
Issue Date:
DOI: https://doi.org/10.1007/BF01270579